The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,180.00
Bid: 1,176.00
Ask: 1,188.00
Change: 12.00 (1.03%)
Spread: 12.00 (1.02%)
Open: 1,170.00
High: 1,210.00
Low: 1,170.00
Prev. Close: 1,168.00
AVON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

14 Mar 2024 09:17

RNS Number : 8635G
Avon Protection PLC
14 March 2024
 

 

14 March 2024

 

Avon Protection plc

Board Update

Appointment of Non-Executive Director

 

Avon Protection plc is pleased to announce the appointment of Maggie Brereton as an independent Non-Executive Director with effect from 1 April 2024.

 

Maggie is Co-founder and CEO of EOS, a specialist provider of deal advisory services. Prior to founding EOS, she was Head of UK Transaction Services at KPMG where she also served as a Board member, chairing the Audit Committee and sitting on the Risk and Remuneration Committees.

 

Maggie brings over 20 years' experience of working on complex transactions and business transformation programmes for both private equity and corporate clients. She also brings significant experience in the industrial sector including aerospace and defence.

 

Maggie will also become a member of the Audit, Remuneration and Nomination Committees from 1 April 2024.

 

There is no other information required to be disclosed pursuant to Listing Rule 9.6.13 in respect of Maggie Brereton.

 

Non-Executive Director Changes

 

As indicated in the annual report released on 21 November 2023, after 8 years as a Non-Executive Director, Chloe Ponsonby planned to step down from the Board during 2024 due to an increase in her executive responsibilities.

 

Chloe Ponsonby will now stand down from the Board on 31 March 2024. Victor Chavez will replace Chloe as Chair of the Remuneration Committee and Bindi Foyle will replace Chloe as Senior Independent Director alongside her role as Audit Committee Chair.

 

Bruce Thompson, Chair, commented:

 

"We are delighted to welcome Maggie to the Board. She brings extensive and valuable experience in identifying value creation opportunities, with a deep focus on the numbers and a real specialisation on analysis and the development of change programmes.

 

This appointment significantly strengthens the Board's experience of implementing and valuing operational and strategic change at a time when these are important elements of the new strategy being taken forward by the leadership team.

 

I wish to extend my sincere thanks to Chloe Ponsonby for her contribution to the Board since her appointment back in March 2016 and for her successful stewardship of remuneration matters. On behalf of the Board, I wish Chloe every success in her new executive role."

 

For further enquiries, please contact:

 

Avon Protection plc

Bruce Thompson, Chair

+44 1225 896 800

Jos Sclater, Chief Executive Officer

About Avon Protection plc:

We are a world leader in protective equipment, with a reputation for innovative design, high-performance quality and specialist materials expertise.

Our two brands, Avon Protection and Team Wendy, supply our respiratory and head protection portfolio to customers across the globe from our manufacturing sites in the UK and North America.

With over 900 talented people our shared purpose and core beliefs are to be #FIERCE about Protecting Lives. It's why we come to work - and it's what motivates us, every day, to do the best work we can.

For further information, please visit our website www.avon-protection-plc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGCGDXUBBDGSS
Date   Source Headline
18th Apr 20241:00 pmRNSHolding(s) in Company
8th Apr 202411:00 amRNSDirectors'/PDMR Shareholdings
5th Apr 20247:00 amRNSHolding(s) in Company
25th Mar 20244:30 pmRNSDirector/PDMR Shareholding
14th Mar 20249:17 amRNSAppointment of Non-Executive Director
6th Mar 20244:17 pmRNSDirectors'/PDMR Shareholdings
20th Feb 20245:00 pmRNSFinal Dividend Currency Exchange Rate
13th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20247:00 amRNSCapital Markets Event
6th Feb 202410:00 amRNSDirectors'/PDMR Shareholdings
5th Feb 20247:00 amRNSNext Generation IHPS Delivery Order
30th Jan 20241:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:00 pmRNSResult of AGM
26th Jan 20247:00 amRNSAGM Trading Update
25th Jan 20243:00 pmRNSPDMR Shareholdings
24th Jan 20247:00 amRNSU.S. Defense Logistics Agency helmet order
15th Jan 20247:00 amRNSGerman Navy underwater rebreather contract
11th Jan 20244:00 pmRNSDirectors'/PDMR Shareholdings
4th Jan 20247:00 amRNSNotice of Capital Markets Event
21st Dec 20233:00 pmRNSHolding(s) in Company
14th Dec 202310:00 amRNSPDMRs’ Interest in Shares
12th Dec 20233:00 pmRNSNotice of Annual Report, Accounts and 2024 AGM
7th Dec 20239:28 amRNSDirector/PDMR Shareholding
27th Nov 20239:00 amRNSHolding(s) in Company
23rd Nov 20236:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSPreliminary Results
7th Nov 20234:00 pmRNSDirector/PDMR Shareholding
20th Oct 20233:00 pmRNSNotification of PDMR Dealing
20th Oct 20231:00 pmRNSDirector/PDMR Shareholding
18th Oct 20236:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
13th Oct 20237:00 amRNSTrading Update & Restatement of FY22 Results
6th Oct 20231:00 pmRNSDirectors'/PDMR Shareholdings
21st Aug 20233:00 pmRNSInterim Dividend Currency Exchange Rate
8th Aug 20231:00 pmRNSDirector/PDMR Shareholding
25th Jul 20232:00 pmRNSHolding(s) in Company
19th Jul 20234:00 pmRNSHolding(s) in Company
14th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 20238:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSU.S. Army Next-Generation Ballistic Helmet Order
27th Jun 20235:00 pmRNSHolding(s) in Company
20th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:00 pmRNSHolding(s) in Company
6th Jun 20232:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20235:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.